These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28452736)

  • 1. [ACTION OF L-CARNITINE, CORVITIN AND THEIR COMBINATION ON FUNCTIONAL STATE OF LIVER IN EXPERIMENTAL MODEL OF REYE SYNDROME IN RATS].
    Ghonghadze M; Antelava N; Liluashvili K; Okujava M; Pachkoria K
    Georgian Med News; 2017 Feb; (263):105-111. PubMed ID: 28452736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [EFFECT OF ACETYLCYSTEINE, CORVITIN AND THEIR COMBINATION ON THE FUNCTIONAL STATE OF LIVER IN RATS WITH PARACETAMOL INDUCED TOXIC HEPATITIS].
    Ghonghadze M; Antelava N; Liluashvili K; Okujava M; Pachkoria K
    Georgian Med News; 2017 Feb; (263):99-105. PubMed ID: 28452735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Sugimoto T; Woo M; Nishida N; Araki A; Murakami K; Kobayashi Y
    Brain Dev; 1990; 12(4):417-22. PubMed ID: 2240462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of phospholipid hepatoprotective agents in experimental Reye syndrome].
    Saratikov AS; Vengerovskiĭ AI; Sukhodolo IV; Chuchalin VS; Arbuzov AG; Cherviakova MB; Burkova VN
    Biull Eksp Biol Med; 2000 Mar; 129(3):337-9. PubMed ID: 10776581
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effect of hepatoprotectors in experimental Reye syndrome].
    Vengerovskiĭ AI; Sukhodolo IV; Chuchalin VS; Arbuzov AG; Cherviakova MB; Mel'nik IuIu; Grishina EI; Fedoreev SA; Saratikov AS
    Eksp Klin Farmakol; 2000; 63(5):68-71. PubMed ID: 11109534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and urinary carnitine and organic acids in Reye syndrome and Reye-like syndrome.
    Sugimoto T; Nishida N; Woo M; Takeuchi T; Yasuhara A; Kobayashi Y; Sakane Y
    Brain Dev; 1986; 8(3):257-61. PubMed ID: 3766902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the possible role of glucose, carnitine, coenzyme Q10 and steroids in the treatment of Reye's syndrome using the margosa oil animal model.
    Sinniah D; Sinniah R; Baskaran G; Pathmanathan R; Yamashita F; Yoshino M
    Acta Paediatr Jpn; 1990 Aug; 32(4):462-8. PubMed ID: 2288230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reye syndrome model in rats: protection against liver abnormalities by L-carnitine and acetyl-L-carnitine.
    Visentin M; Bellasio R; Tacconi MT
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1069-75. PubMed ID: 7473134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine status in Reye and Reye-like syndromes.
    Matsuda I; Ohtani Y
    Pediatr Neurol; 1986; 2(2):90-4. PubMed ID: 3508684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reye syndrome and liver transplantation.
    Cağ M; Saouli AC; Audet M; Wolf P; Cinqualbre J
    Turk J Pediatr; 2010; 52(6):662-4. PubMed ID: 21428204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fructose-induced hepatic gluconeogenesis: effect of L-carnitine.
    Rajasekar P; Anuradha CV
    Life Sci; 2007 Mar; 80(13):1176-83. PubMed ID: 17239403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of N-acetylcysteine, caffeic acid and vitamin E on doxorubicin hepatotoxicity.
    Gokcimen A; Cim A; Tola HT; Bayram D; Kocak A; Ozgüner F; Ayata A
    Hum Exp Toxicol; 2007 Jun; 26(6):519-25. PubMed ID: 17698947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effect of mycophenolate mofetil against nephrotoxicity and hepatotoxicity induced by tacrolimus in Wistar rats.
    Ferjani H; El Arem A; Bouraoui A; Achour A; Abid S; Bacha H; Boussema-Ayed I
    J Physiol Biochem; 2016 Jun; 72(2):133-44. PubMed ID: 26746208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased serum carnitine in valproate induced Reye syndrome.
    Böhles H; Richter K; Wagner-Thiessen E; Schäfer H
    Eur J Pediatr; 1982 Nov; 139(3):185-6. PubMed ID: 6819143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperbaric oxygen treatment and N-acetylcysteine ameliorate acetaminophen-induced liver injury in a rat model.
    Taslipinar MY; Aydin I; Kaldirim U; Aydin FN; Agilli M; Eyi YE; Tuncer SK; Altayli E; Ucar F; Macit E; Toygar M; Yigit N; Cayci T
    Hum Exp Toxicol; 2013 Oct; 32(10):1107-16. PubMed ID: 23925941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue carnitine in Reye syndrome.
    Willner JH; Chutorian AM; DiMauro S
    Ann Neurol; 1978 Nov; 4(5):468-9. PubMed ID: 736529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of L-carnitine, N-acetylcysteine and genistein in an experimental model of liver fibrosis.
    Demiroren K; Dogan Y; Kocamaz H; Ozercan IH; Ilhan S; Ustundag B; Bahcecioglu IH
    Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):63-72. PubMed ID: 24239319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver damage with non-narcotic analgesics.
    Prescott LF
    Med Toxicol; 1986; 1 Suppl 1():44-56. PubMed ID: 3547001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.
    Abdin A; Sarhan N
    Can J Physiol Pharmacol; 2014 Sep; 92(9):780-8. PubMed ID: 25162205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of 4-pentenoic acid-induced liver injury in rats by 16,16-dimethyl PGE2.
    Hidaka T; Inokuchi T; Nakamura Y; Kotegawa M; Sugiyama M; Ogura R
    Exp Mol Pathol; 1991 Oct; 55(2):135-42. PubMed ID: 1936211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.